9 October 2015

Synergy Healthcare


04/06/2003 Leslie Copeland

The provider of specialist cleaning services to hospitals surged after the group produced stunning figures for the year to the end of March. Pre-tax profits rose 61 per cent to £2.4m as sales more than doubled to £27.1m after bedding down the £11.5m acquisition of Hays Clinical Support Services in April 2002. Synergy's existing business - split between Healthtex, which hires out and cleans linen on seven-year contracts, and the higher margin surgical cleaning division where contracts last 15 years - also displayed decent organic growth as six new contracts were won. The group now boasts a strong forward book in excess of £160m and chief executive Dr Richard Steeves expects this to grow as its major sterile services market should shortly see substantial NHS-backed changes. To fund the Hays acquisition Synergy raised £12m via a placing at 210p. This meant adjusted earnings per share improved 27% to 10p per share, exceeding brokers' forecasts. Synergy should manage to repeat the trick this year. Ian Jermin of Baird envisages earnings of 11.1p, putting Synergy's shares on a prospective p/e of 16. Operating margins should improve as the Hays business continues to be rectified and more contracts to clean operating theatres are won. The stock still trades below last year's placing price - with £6.7m cash remaining this seems unfair. Buy.

Sector: Health Care Equipment & Services

Companies: Synergy Healthcare

Market cap: £39.3m

PE Forecast: 16

Share price: 178p

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. You can purchase the directory at the pre-order price with a 15% saving (+VAT). Offer valid until 6th October 2015. Order your copy today


Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.

What Investment magazine: save 45% on the shop price

Be the first to receive our independent analysis and research, designed to help you generate more wealth for you and your family over the long term. Subscribe and save.

Popular Recommendations